191 related articles for article (PubMed ID: 24185433)
41. Evaluating patient satisfaction with pharmacist-administered long-acting injectable antipsychotics in the community pharmacy.
Mooney EV; Hamper JG; Willis RT; Farinha TL; Ricchetti CA
J Am Pharm Assoc (2003); 2018; 58(4S):S24-S29.e2. PubMed ID: 30006184
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of a pilot medication therapy management project within the North Carolina State Health Plan.
Christensen DB; Roth M; Trygstad T; Byrd J
J Am Pharm Assoc (2003); 2007; 47(4):471-83. PubMed ID: 17616493
[TBL] [Abstract][Full Text] [Related]
43. Pharmacist-led depression screening and intervention in an underserved, rural, and multi-ethnic diabetic population.
Wilson C; Twigg G
J Am Pharm Assoc (2003); 2018; 58(2):205-209. PubMed ID: 29217142
[TBL] [Abstract][Full Text] [Related]
44. Regional osteoporosis screening, referral, and monitoring program in community pharmacies: findings from Project ImPACT: Osteoporosis.
Goode JV; Swiger K; Bluml BM
J Am Pharm Assoc (2003); 2004; 44(2):152-60. PubMed ID: 15098849
[TBL] [Abstract][Full Text] [Related]
45. Pharmacist intervention in colorectal cancer screening initiative.
Holle LM; Levine J; Buckley T; White CM; White C; Hadfield MJ
J Am Pharm Assoc (2003); 2020; 60(4):e109-e116. PubMed ID: 32197754
[TBL] [Abstract][Full Text] [Related]
46. A community pharmacy-based cardiovascular screening service: views of service users and the public.
Taylor J; Krska J; Mackridge A
Int J Pharm Pract; 2012 Oct; 20(5):277-84. PubMed ID: 22953766
[TBL] [Abstract][Full Text] [Related]
47. The sensitivity and specificity of subjective memory complaints and the subjective memory rating scale, deterioration cognitive observee, mini-mental state examination, six-item screener and clock drawing test in dementia screening.
Ramlall S; Chipps J; Bhigjee AI; Pillay BJ
Dement Geriatr Cogn Disord; 2013; 36(1-2):119-35. PubMed ID: 23860433
[TBL] [Abstract][Full Text] [Related]
48. Patient expectations and willingness to use primary care pharmacy services in the United Arab Emirates.
Hasan S; Sulieman H; Stewart K; Chapman CB; Kong DC
Int J Pharm Pract; 2015 Oct; 23(5):340-8. PubMed ID: 25628224
[TBL] [Abstract][Full Text] [Related]
49. Patient awareness, willingness, and barriers to point-of-care hepatitis C screening in community pharmacy.
Brewer A; Hanna C; Eckmann L; Schadler A; Divine H
J Am Pharm Assoc (2003); 2018; 58(4S):S69-S72.e1. PubMed ID: 30006188
[TBL] [Abstract][Full Text] [Related]
50. Pharmacist-initiated hepatitis C virus screening in a community pharmacy to increase awareness and link to care at the medical center.
Isho NY; Kachlic MD; Marcelo JC; Martin MT
J Am Pharm Assoc (2003); 2017; 57(3S):S259-S264. PubMed ID: 28506379
[TBL] [Abstract][Full Text] [Related]
51. Using motivational interviewing in the community pharmacy to increase adult immunization readiness: A pilot evaluation.
Brackett A; Butler M; Chapman L
J Am Pharm Assoc (2003); 2015; 55(2):182-6. PubMed ID: 25615903
[TBL] [Abstract][Full Text] [Related]
52. Independent community pharmacist interest in participating in community pharmacy research networks.
Carr MB; Divine H; Hanna C; Freeman PR; Blumenschein K
J Am Pharm Assoc (2003); 2011; 51(6):727-33. PubMed ID: 22068194
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of a Community Pharmacy-Based Screening Questionnaire to Identify Patients at Risk for Drug Therapy Problems.
Pammett RT; Blackburn D; Taylor J; Mansell K; Kwan D; Papoushek C; Jorgenson D
Pharmacotherapy; 2015 Sep; 35(9):881-6. PubMed ID: 26406776
[TBL] [Abstract][Full Text] [Related]
54. The 'third class' of medications: Sales and purchasing behavior are associated with pharmacist only and pharmacy medicine classifications in Australia.
Emmerton L
J Am Pharm Assoc (2003); 2009; 49(1):31-7. PubMed ID: 19196594
[TBL] [Abstract][Full Text] [Related]
55. Practice change in community pharmacy: quantification of facilitators.
Roberts AS; Benrimoj SI; Chen TF; Williams KA; Aslani P
Ann Pharmacother; 2008 Jun; 42(6):861-8. PubMed ID: 18477730
[TBL] [Abstract][Full Text] [Related]
56. Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation.
Wells KM; Thornley T; Boyd MJ; Boardman HF
Res Social Adm Pharm; 2014; 10(1):58-71. PubMed ID: 23608701
[TBL] [Abstract][Full Text] [Related]
57. Preferences for the delivery of community pharmacy services to help manage chronic conditions.
Whitty JA; Kendall E; Sav A; Kelly F; McMillan SS; King MA; Wheeler AJ
Res Social Adm Pharm; 2015; 11(2):197-215. PubMed ID: 25116938
[TBL] [Abstract][Full Text] [Related]
58. Cross-sectional survey of community pharmacists' views of the electronic Minor Ailment Service in Scotland.
Paudyal V; Hansford D; Scott Cunningham IT; Stewart D
Int J Pharm Pract; 2010 Aug; 18(4):194-201. PubMed ID: 20636670
[TBL] [Abstract][Full Text] [Related]
59. Performance of community pharmacists in providing clinical medication reviews.
Laaksonen R; Duggan C; Bates I
Ann Pharmacother; 2010; 44(7-8):1181-90. PubMed ID: 20571102
[TBL] [Abstract][Full Text] [Related]
60. Investigation of patients' demand for community pharmacies: relationship between pharmacy services and patient satisfaction.
Kamei M; Teshima K; Fukushima N; Nakamura T
Yakugaku Zasshi; 2001 Mar; 121(3):215-20. PubMed ID: 11265116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
